Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: Role of platelet-derived growth factor pathway

Critical Care Medicine

Volumn 40, Issue 7, 2012, Pages 2041-2049

  Piednoir, Pascale ^a,c   Quesnel, Christophe ^a,b   Nardelli, Laurent ^a   Leçon, Véronique ^c   Bouadma, Lila ^c   Lasocki, Sigismond ^c   Philip, Ivan ^c   Mailleux, Arnaud ^a   Soler, Paul ^a   Crestani, Bruno ^a   Dehoux, Monique ^a,c  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Acute respiratory distress syndrome; bronchoalveolar lavage fluid; fibroblast; fibrosis; migration; platelet derived growth factor; repair

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; GROWTH FACTOR; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SOLUBLE PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CELL MIGRATION; CHEMOTAXIS; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTENSIVE CARE UNIT; LUNG FIBROBLAST; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING;

ACUTE LUNG INJURY; AGED; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CELL MOVEMENT; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-8; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; NEUTROPHILS; PLATELET-DERIVED GROWTH FACTOR; PROSPECTIVE STUDIES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEVERITY OF ILLNESS INDEX; TYRPHOSTINS;

EID: 84862729016     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31824e65ba     Document Type: Article

References (40)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349 (Pubitemid 30408719)
2. Shimabukuro DW, Sawa T, Gropper MA: Injury and repair in lung and airways. Crit Care Med 2003; 31(Suppl 8):S524-S531
3. Young L, Adamson IY: Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ Health Perspect 1993; 101:56-61 (Pubitemid 23197121)
4. Rocco PR, Dos Santos C, Pelosi P: Lung parenchyma remodeling in acute respiratory distress syndrome. Minerva Anestesiol 2009; 75:730-740
5. Meduri GU: Late adult respiratory distress syndrome. New Horiz 1993; 1:563-577
6. Bitterman PB: Pathogenesis of fibrosis in acute lung injury. Am J Med 1992; 92(6A):39S-43S
7. Marshall RP, Bellingan G, Webb S, et al: Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000; 162:1783-1788
8. Papazian L, Doddoli C, Chetaille B, et al: A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007; 35:755-762 (Pubitemid 46407787)
9. Martin C, Papazian L, Payan MJ, et al: Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995; 107:196-200
10. Tager AM, LaCamera P, Shea BS, et al: The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008; 14:45-54
11. Li Y, Jiang D, Liang J, et al: Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med 2011; 208:1459-1471
12. Selman M, Carrillo G, Estrada A, et al: Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE 2007; 2:e482
13. Svee K, White J, Vaillant P, et al: Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 1996; 98:1713-1727 (Pubitemid 26359187)
14. Snyder LS, Hertz MI, Peterson MS, et al: Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest 1991; 88:663-673
15. Quesnel C, Nardelli L, Piednoir P, et al: Alveolar fibroblasts in acute lung injury: Biological behaviour and clinical relevance. Eur Respir J 2010; 35:1312-1321
16. Quesnel C, Piednoir P, Gelly J, et al: Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury. Crit Care Med 2012; 40:21-28
17. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1):818-824 (Pubitemid 24082248)
18. Quesnel C, Marchand-Adam S, Fabre A, et al: Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 294:L334-L343 (Pubitemid 351253370)
19. Rice AB, Moomaw CR, Morgan DL, et al: Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol 1999; 155:213-221 (Pubitemid 29318719)
20. Tiesman J, Hart CE: Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J Biol Chem 1993; 268:9621-9628 (Pubitemid 23146020)
21. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36 (Pubitemid 12142173)
22. Chang HY, Chi JT, Dudoit S, et al: Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99:12877-12882
23. Shimokado K, Raines EW, Madtes DK, et al: A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985; 43:277-286 (Pubitemid 16199714)
24. Andersson M, Ostman A, Bäckström G, et al: Assignment of interchain disulfide bonds in platelet-derived growth factor (PDGF) and evidence for agonist activity of monomeric PDGF. J Biol Chem 1992; 267:11260-11266
25. Shim AH, Liu H, Focia PJ, et al: Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex. Proc Natl Acad Sci USA 2010; 107:11307-11312
26. Wang L, Cummings R, Zhao Y, et al: Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-beta in human bronchial epithelial cells. J Biol Chem 2003; 278:39931-39940 (Pubitemid 37248557)
27. Ball SG, Shuttleworth CA, Kielty CM: Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol 2007; 177:489-500 (Pubitemid 46718277)
28. Cerutis DR, Dreyer AC, Vierra MJ, et al: Lysophosphatidic acid modulates the healing responses of human periodontal ligament fibroblasts and enhances the actions of platelet-derived growth factor. J Periodontol 2007; 78:1136-1145
29. Choi JE, Lee SS, Sunde DA, et al: Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury. Am J Respir Crit Care Med 2009; 179:212-219
30. Bonner JC: Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 2004; 15:255-273 (Pubitemid 38781050)
31. Boyle JE, Lindroos PM, Rice AB, et al: Prostaglandin-E2 counteracts interleukin-1beta-stimulated upregulation of platelet-derived growth factor alpha-receptor on rat pulmonary myofibroblasts. Am J Respir Cell Mol Biol 1999; 20:433-440 (Pubitemid 129504865)
32. Wang YZ, Zhang P, Rice AB, et al: Regulation of interleukin-1beta-induced platelet-derived growth factor receptor-alpha expression in rat pulmonary myofibroblasts by p38 mitogen-activated protein kinase. J Biol Chem 2000; 275:22550-22557 (Pubitemid 30621846)
33. Suter PM, Suter S, Girardin E, et al: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145:1016-1022
34. Park WY, Goodman RB, Steinberg KP, et al: Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164(10 Pt 1):1896-1903 (Pubitemid 33152327)
35. Goodman RB, Strieter RM, Martin DP, et al: Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 154(3 Pt 1):602-611 (Pubitemid 26327279)
36. Rose-John S, Heinrich PC: Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994; 300 (Pt 2):281-290 (Pubitemid 24167878)
37. Nemoto E, Kanaya S, Minamibuchi M, et al: Cleavage of PDGF receptor on periodontal ligament cells by elastase. J Dent Res 2005; 84:629-633 (Pubitemid 43827844)
38. Li X, Pérez L, Pan Z, et al: The transmembrane domain of TACE regulates protein ectodomain shedding. Cell Res 2007; 17:985-998 (Pubitemid 350261796)
39. Kohyama T, Ertl RF, Valenti V, et al: Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 2001; 281:L1257-L1263
40. White ES, Atrasz RG, Dickie EG, et al: Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am J Respir Cell Mol Biol 2005; 32:135-141 (Pubitemid 40189695)